EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial

Kamel Mohammedi iD, Sibylle Hess, Matthew McQueen, Marie Pigeyre, Shun Fu Lee, Guillaume Pare, Hertzel C Gerstein iD

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15654 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Kamel Mohammedi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To assess clinical and biochemical measurements that can identify people with dysglycaemia (i.e. diabetes or pre‐diabetes) who remain free of serious outcomes during follow‐up. Materials and Methods We conducted exploratory analyses using data from the Outcomes Reduction with an Initial Glargine Intervention (ORIGIN) study to identify independent determinants of outcome‐free status in 12 537 middle‐aged and older adults with prediabetes and early type 2 diabetes from 40 countries. Serious outcome‐free status was defined as the absence of major cardiovascular outcomes, kidney or retinal outcomes, peripheral artery disease, dementia, cancer, any hospitalization, or death during follow‐up.

Results

In total, 3328 (26.6%) participants remained free of serious outcomes during a median follow‐up of 6.2 years (IQR 5.8, 6.7). Independent clinical determinants of outcome‐free status included younger age, female sex, non‐White ethnicity, shorter diabetes duration, absence of previous cardiovascular disease, current or former smokers, higher grip strength, Mini‐Mental State Examination score, and ankle‐brachial index, lower body mass index and kidney disease index, and non‐use of renin‐angiotensin system drugs and beta‐blockers. In a subset of 8401 people with baseline measurements of 238 biomarkers, growth differentiation factor 15, kidney injury molecule‐1, N‐terminal pro‐brain natriuretic peptide, uromodulin, C‐reactive protein, factor VII and ferritin were independent determinants. The combination of clinical determinants and biomarkers best identified participants who remained outcome‐free (C‐statistics 0.71, 95% confidence interval 0.70‐0.73; net reclassification improvement 0.55, 95% confidence interval 0.48‐0.58).

Conclusions

A set of routinely measured clinical characteristics and seven protein biomarkers identify middle‐aged and older people with prediabetes or early type 2 diabetes as least likely to experience serious outcomes during follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Prediabetic StateHumansFemaleMaleMiddle AgedAgedCardiovascular DiseasesFollow-Up StudiesHypoglycemic AgentsBiomarkersAnkle Brachial IndexPeptide FragmentsC-Reactive ProteinNatriuretic Peptide, Brain

Stichwörter der Autor:innen

cancercardiovascular diseasedysglycaemiakidney diseaseretinopathytype 2 diabetes

Substanzen

Hypoglycemic AgentsBiomarkersPeptide Fragmentspro-brain natriuretic peptide (1-76)C-Reactive ProteinNatriuretic Peptide, Brain

Autor:innen und Institutionen

  • Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada.
  • Université de Bordeaux, INSERM, BMC, U1034, Avenue de Magellan, Pessac, France.
  • Sanofi, Global Medical Diabetes, Frankfurt, Germany.

ORCID-Profile: Kamel Mohammedi, Hertzel C Gerstein

Zitieren

APA

Mohammedi, K., Hess, S., McQueen, M., Pigeyre, M., Lee, S. F., Pare, G., & Gerstein, H. C. (2024). Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15654

Vancouver

Mohammedi K, Hess S, McQueen M, Pigeyre M, Lee SF, Pare G, et al. Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15654

BibTeX
@article{Mohammedi2024,
  author = {Mohammedi, Kamel and Hess, Sibylle and McQueen, Matthew and Pigeyre, Marie and Lee, Shun Fu and Pare, Guillaume and Gerstein, Hertzel C},
  title = {Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15654}
}
Kostenlos starten →